Loading market information…
PAR · AFME.PA · EUR
Stock price, earnings
Quote as of Feb 3, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Affluent Medical S.A.’s quoted price sits in the upper half of its reported 52-week range, 4.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Affluent Medical S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Affluent Medical S.A., a French enterprise, specializes in the creation of minimally invasive medical solutions designed to address cardiovascular and vascular conditions. Its product pipeline includes the Kardiozis technology, engineered to manage abdominal aortic aneurysms, alongside the Kalios and Epygon implants, which target mitral insufficiency. Additionally, the company offers the Artus implant, an advanced electromechanical artificial sphincter devised for the comprehensive treatment of severe urinary incontinence in both female and male patients. Established in 2011, its headquarters are situated in Aix-en-Provence, France.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
